Where the Sovereign AI Growth Sits: Mapping the 40B to 148B Market by Regulation and Vertical
The sovereign AI market is forecast to grow from USD 40B in 2025 to USD 148B by 2032, and the shape of that growth is set by the regulations that bar regulated industries from public-cloud AI.
By Micky Irons, founder and CEO of Mickai
The headline number is easy to quote and easy to misread. The sovereign AI market is projected to grow from USD 40B in 2025 to USD 148B by 2032. What that figure hides is where the growth actually sits. This is not a story about AI getting bigger everywhere at once. It is a story about a specific class of buyer who cannot legally put their data through a public-cloud model, and who therefore needs AI they own and run inside their own walls. The market structure follows the regulation, not the noise.
At Mickai we built for exactly that buyer. Mickai is a sovereign AI operating system: AI that regulated businesses own and run on-prem and air-gapped, with every action written to a tamper-evident, post-quantum-signed audit record (OAR). It is built and live. The growth map below is the map we built against.
The regulation is the demand signal
Sovereign AI demand does not come from preference. It comes from law. When you break the market down by the rules that create it, the 148B figure stops being abstract and becomes a set of named obligations with named owners.
In UK financial services, PRA SS2/21 governs outsourcing and third-party risk. It pushes regulated firms toward control, exit rights, and full auditability over critical systems. An AI model that processes risk decisions inside a hyperscaler the firm cannot inspect is a hard fit for that standard. In healthcare, the NHS Data Security and Protection Toolkit and UK GDPR special-category rules govern patient data, which cannot be casually routed to a public endpoint. Across the EU, the AI Act places high-risk obligations on systems used in credit, insurance, employment, and essential services, with documentation and human-oversight duties that a black-box public model struggles to satisfy.
Then there is the jurisdictional layer. ITAR and EAR restrict defence and dual-use data from crossing borders or touching foreign-controlled infrastructure. The NIS Regulations cover operators of essential services. The US CLOUD Act means data held by a US hyperscaler can be reached by US authorities regardless of where it physically sits, which is precisely the exposure a European bank or hospital is told to avoid. Each of these is not a soft preference. Each is a wall. And on the wrong side of every wall sits a buyer who still wants AI.
The wedge: who is actually barred
Put numbers to the walls. Around 0.85M UK businesses, roughly 15% of the total, and around 5M across the EU operate under rules that effectively bar them from running their regulated workloads through public-cloud AI. That is the wedge. It is not a niche. It is the regulated core of two of the largest economies on earth: the banks, insurers, hospitals, defence suppliers, and critical-infrastructure operators that the rest of the system depends on.
This is the part of the 40B-to-148B curve that compounds. General-purpose AI spend is contested by everyone. Sovereign AI spend is reserved for vendors who can actually meet the control, residency, and audit requirements. Most cannot. The barrier to entry is not model quality. It is provable sovereignty.
Mapping the growth by vertical
Once you accept that regulation defines the buyer, the vertical map writes itself, and it is the map our Studios were built to cover.
Financial services is the largest near-term pool, driven by SS2/21, AML obligations, and model-risk governance. Our Nemesis Studio addresses fraud and AML, Plutus covers finance operations, and Tyche handles underwriting, all running inside the firm with the audit record attached. Insurance and lending lean on Tyche and on Prometheus for forecasting. Healthcare, gated by the DSP Toolkit and special-category data, is served by Panacea for clinical work. Compliance-heavy functions across every vertical run on Nomos for compliance, Astraea for legal, Aletheia for audit, and Pythia for business intelligence, with Iris handling regulated customer service.
The point is not the names. The point is that each Studio maps to a regulated function where the public-cloud route is closed, and each ships with the sovereign substrate underneath: on-prem, air-gapped where required, every action signed into the audit record. Alongside the Studios sit Trust Agent, the AMT marketing system, Vinis voice, OAR-as-a-Service, and HELIOS hardware, so the offering spans the full stack a regulated buyer needs rather than a single app.
Why the moat holds
A growth map is only worth holding if you can defend your position on it. Our defence is an IP estate of 104 filed UK patent applications, roughly 2,340 claims, held by Mickai LTD with myself as named inventor. Filed, not granted: what that buys is priority and a prior-art moat over the core methods of sovereign, audit-anchored AI. In a market defined by who can provably meet regulation, owning the foundational methods is the position that compounds.
That estate also reads as a licensing surface. Our analysis maps 196 companies and 311 patent-company pairs as potential licensees, including names like Microsoft, AWS, NVIDIA, Google, Adobe, and IBM. That is potential-licensee sizing, not signed revenue, but it frames the strategic shape: the same methods that let a regulated firm run AI sovereignly are methods the hyperscalers themselves will need as their own customers hit these walls. Mickai is an ally to that ecosystem, not an attempt to replace it. The dual-buyer thesis is straightforward. The regulated enterprise buys the operating system. The platform owner has reason to want the methods.
The momentum, dated
Momentum is a signal, not a substitute for substance, so I will give it once and move on. As of June 2026, third-party data on Crunchbase ranked me at #4, with the Mickai company in the top 1-2% globally. Mickai is a UK company with Birmingham manufacturing secured, building to scale and heading for the top of this category. The map above is why that climb has direction: we are not chasing a general market, we are positioned at the regulated core of a market that grows because the law makes it grow.
What this means
The economics follow the structure. A Year 5 revenue path to billions at high gross margin is underwritten by two things at once: the IP estate and the dual-buyer thesis. A category defined by provable sovereignty, anchored by a foundational patent position, with a regulated buyer base that compounds rather than churns, is the kind of category a hyperscaler would rather own than compete with. Mickai is already built, already live, and mapping its growth against the regulation that creates the demand.
Contact: micky@mickai.co.uk
FAQ
Frequently asked questions
What is driving the sovereign AI market from 40B to 148B?
Regulation, not preference. Rules like PRA SS2/21, UK GDPR special-category data, the NHS DSP Toolkit, the EU AI Act high-risk regime, ITAR and EAR, the NIS Regulations, and the US CLOUD Act effectively bar regulated firms from routing sensitive workloads through public-cloud AI. That creates a reserved pool of demand for AI that buyers can own and run inside their own walls.
Who is barred from using public-cloud AI?
Around 0.85M UK businesses, roughly 15% of the total, and around 5M across the EU operate under rules that effectively close the public-cloud route for their regulated workloads. This is the regulated core: banks, insurers, hospitals, defence suppliers, and critical-infrastructure operators.
What is Mickai?
Mickai is a sovereign AI operating system (SIOS): AI that regulated businesses own and run on-prem and air-gapped, with every action written to a tamper-evident, post-quantum-signed audit record. It is built and live, with Greek-named Studios mapped to regulated functions such as fraud and AML, finance, underwriting, forecasting, compliance, legal, clinical work, audit, and business intelligence.
How is Mickai's position defended?
Through 104 filed UK patent applications, roughly 2,340 claims, held by Mickai LTD with Micky Irons as named inventor. Filed not granted, the estate establishes priority and a prior-art moat over the core methods of sovereign, audit-anchored AI. Analysis also maps 196 companies and 311 patent-company pairs as potential licensees, which is potential-licensee sizing rather than signed revenue.
Is Mickai trying to replace the hyperscalers?
No. Mickai is an ally to that ecosystem under a dual-buyer thesis. The regulated enterprise buys the operating system, and the platform owners have reason to want the underlying methods as their own customers hit the same regulatory walls.